“Media studies explain it like a loophole,” says Alliance for Pharmacy Compounding CEO Scott Brunner. “It’s not a loophole. It’s extremely intentional coverage.” Brunner has expressed aggravation about how some coverage in the rise of compounding GLP-1s conflates unlicensed pharmacies peddling copyright drugs or analysis peptides wi